Vimarsana
Biggest News Aggregation in the World

Impact Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Impact Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Impact Trial Today - Breaking & Trending Today

England's vision for an end to new cases of HIV by 2030 is on track - Vimarsana News

England's vision for an end to new cases of HIV by 2030 is on track

Published: November 30, 2023

Using a combination of pre-existing HIV drugs, a medicine for HIV-negative people taken before sex has reduced the chances of getting the virus by 86% and considerably reduced HIV contraction in real-world situations across several years of use.

Source: outsourcing-pharma.com
Related Topics:
United KingdomJohn SaundersJohn StewartAnn SullivanKevin FentonRoger ChinnAction Plan Implementation Steering GroupCare ResearchUnited Kingdom Health Security AgencyNational Institute Of HealthOur NationalImpact Trial Oversight BoardWestminster HospitalNational InstituteImpact TrialClinical DevelopmentDrug DeliveryMarkets Amp RegulationsAtient CentricityPis Active Pharmaceutical Ingredients Data ManagementRegulatory AffairsHiv InfectionHiv Drugs
Without PrEP, a Third of New HIV Cases Occur in MSM at Low Risk - Vimarsana News

Without PrEP, a Third of New HIV Cases Occur in MSM at Low Risk

Published: October 30, 2021

Lower barriers to HIV pre-exposure prophylaxis may capture people who are missed through screening but could benefit from the prevention pill.

Source: medscape.com
Related Topics:
New YorkUnited StatesTemple UniversityUnited KingdomCity OfAnn SullivanAntonio UrbinaGina SimonciniUnited Kingdom National Health ServiceGilead SciencesUs Centers For DiseaseMount Sinai Medical Center PrHealthcare FoundationSociety ConferenceHealthcare Foundation CenterIcahn School Of MedicineWestminster HospitalDisease ControlMedscape Medical NewsMount Sinai Medical CenterNew York CityIcahn SchoolImpact TrialFoundation HealthcareViiv Healthcare